Publications
Publications
Show Results For
- All HBS Web
(875)
- Faculty Publications (375)
- November 1995 (Revised February 1996)
- Case
Monsanto Company: The Coming of Age of Bio-Technology
By: Ray A. Goldberg and Thomas N. Urban Jr
Monsanto has one product, Roundup, accounting for 30% of company net income and is going off patent. How should the company position itself and its products in the future? View Details
- November 1995 (Revised February 2017)
- Case
Luna Pen (A)
By: Kathleen McGinn and Michael Wheeler
Discusses the negotiation of a possible trademark infringement involving a German conglomerate and a Taiwanese trading firm. View Details
- May 1995
- Teaching Note
C.K. Coolidge, Inc. (A) TN
By: David E. Bell
Teaching Note for (9-894-017). View Details
- January 1995 (Revised November 1995)
- Case
Candela Laser vs. Cynosure, Inc.
By: Josh Lerner and Benjamin Conway
Summarizes the lawsuit by Candela Laser against its former CEO and founder, who has begun a competing firm. The extent of patent and trade secret protection are crucial issues. View Details
- Article
Some Reflections on the Antitrust Treatment of Intellectual Property
By: Tracy R. Lewis and Dennis A. Yao
Abridged version in The Financial Times, The Complete MBA Companion, 1997, pp. 577-582. View Details
- November 1994 (Revised January 2006)
- Background Note
An Introduction to Patents and Trade Secrets
By: Josh Lerner
Provides an overview of patent and trade secret protection. Also discusses the legal processes through which intellectual property is protected and litigated. View Details
- summer 1994
- Article
The Importance of Patent Scope: An Empirical Analysis
By: J. Lerner
Keywords: Patents
- March 1994
- Article
Expropriation and Inventions: Appropriable Rents in the Absence of Property Rights
By: J. Anton and Dennis Yao
We analyze the problem faced by a financially weak independent inventor when selling a valuable, but easily imitated, invention for which no property rights exist. The inventor can protect his or her intellectual property by negotiating a contingent contract (with a... View Details
- January 1994 (Revised November 1997)
- Case
Aberlyn Capital Management: July 1993
By: Josh Lerner and Peter Tufano
Aberlyn Capital Management, a venture leasing firm specializing in providing capital to biotechnology firms, proposes to introduce a new product. Aberlyn will base a lease on an intangible product: the patent of a biotechnology firm. This poses a series of short and... View Details
- September 1993
- Supplement
Manufacturing at ALZA: The Right Prescription? (B)
ALZA, a drug delivery company, must decide what and for whom to manufacture. In the past, it has licensed to pharmaceutical companies its patented system for the slow release of drugs into the human system. Therefore the company has little experience in choice of drug... View Details
- Article
Geographic Localization of Knowledge Spillovers as Evidenced by Patent Citations
By: Rebecca M. Henderson, Adam Jaffe and Manuel Trajtenberg
- April 1993 (Revised February 1996)
- Supplement
ALZA and Bio-Electro Systems (B1): Rights Offering Strategy
By: Josh Lerner and Peter Tufano
Supplements the (A) case. Describes the CEO's decision. View Details
- April 1993 (Revised February 1996)
- Supplement
ALZA and Bio-Electro Systems (B2): The Rights Offering
By: Josh Lerner and Peter Tufano
Supplements the (A) case. Describes the implementation of the CEO's decision. View Details
Keywords: Intellectual Property
- October 1992 (Revised September 1993)
- Case
Nopane Advertising Strategy
By: David E. Bell
Nopane is a proprietary drug that sells in much of the United States. It faces substantial competition. The brand manager is undertaking an experiment to determine whether ad copy should be emotional-based or rational-based. The data and associated regression results... View Details
- February 1992 (Revised April 1995)
- Case
Pfizer: Global Protection of Intellectual Property
By: Lynn S. Paine and Michael Santoro
Top officials at Pfizer are assessing their strategy for improving protection of Pfizer's patents around the world. The outcome of the Uruguay Round of the GATT negotiations is uncertain, and it is not clear whether an acceptable intellectual property protection... View Details
- 1991
- Working Paper
Manufacturing, Firm Boundaries, and the Protection of Intellectual Property
By: Gary P. Pisano and Paul Mang
- September 1991 (Revised February 1993)
- Case
Burroughs Wellcome and AZT (A)
Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S.... View Details
- summer 1991
- Article
Trade Secrets and the Justification of Intellectual Property: A Comment on Hettinger
By: L. S. Paine
Keywords: Intellectual Property
- January 1991 (Revised January 1992)
- Supplement
IBM-Fujitsu Settlement
Describes the decision by the arbitrators chosen to resolve the intellectual property dispute between IBM and Fujitsu. View Details